Neogenomics Aktie
13,50
EUR
-0,30
EUR
-2,17
%
14,20
USD
+0,22
USD
+1,57
%
Werbung
Neogenomics Aktie Analyse
01.05.19 | Neogenomics Buy | Needham & Company, LLC | |
29.03.19 | Neogenomics Buy | Needham & Company, LLC | |
03.01.19 | Neogenomics Buy | Needham & Company, LLC | |
24.10.18 | Neogenomics Strong Buy | First Analysis Securities | |
02.05.18 | Neogenomics Equal-Weight | First Analysis Securities | |
11.09.17 | Neogenomics Neutral | BTIG Research | |
24.08.17 | Neogenomics Buy | Gabelli & Co | |
15.12.16 | Neogenomics Overweight | Cantor Fitzgerald | |
Werbung
|
|||
04.10.16 | Neogenomics Overweight | First Analysis Securities | |
28.04.16 | Neogenomics Buy | The Benchmark Company | |
11.03.16 | Neogenomics Buy | The Benchmark Company | |
26.10.15 | Neogenomics Buy | ROTH Capital Partners, LLC | |
13.07.15 | Neogenomics Buy | ROTH Capital Partners, LLC | |
07.04.09 | Neogenomics | Global Biotech Investing | |
21.08.07 | Neogenomics | Global Biotech Investing |
Werbung